Cytoreductive Surgery and Peritonectomy Procedures.

Area of Science:

• Surgical Oncology
• Gastroenterology
• Cancer Treatment

Background:

• Peritoneal metastases (PM) present a significant challenge in various cancers.
• Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is an established treatment modality for PM.
• CRS aims for complete macroscopic disease removal through peritonectomy and visceral resections.

Purpose of the Study:

• To review the techniques for performing CRS.
• To outline current recommendations for CRS procedures.
• To provide guidance on patient selection for CRS and HIPEC.

Main Methods:

• Review of existing literature on CRS techniques.
• Analysis of current surgical guidelines and expert recommendations.
• Discussion of peritonectomy and visceral resection strategies.

Main Results:

• CRS involves complex procedures requiring specialized surgical skills.
• Appropriate patient selection is crucial for successful outcomes.
• Standardized techniques and recommendations enhance the efficacy of CRS.

Conclusions:

• CRS and HIPEC offer a viable treatment option for patients with peritoneal metastases.
• Mastery of surgical techniques and careful patient selection are paramount.
• Adherence to current recommendations can optimize treatment outcomes.